Northwestern Mutual Wealth Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-432	Closed	-$47K	–	2636
2016 Q4	$47K	Buy	+432	New	+$50.5K	﹤0.01%	1048
2016 Q3	–	Sell	-425	Closed	-$45K	–	1911
2016 Q2	$45K	Hold	425	–	–	﹤0.01%	938
2016 Q1	$49K	Buy	+425	New	+$49.9K	﹤0.01%	904

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Northwestern Mutual Wealth Management's CBPO Position: Q1 2017 in Review

Northwestern Mutual Wealth Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 432 shares — an estimated $47K sold.

Northwestern Mutual Wealth Management first reported a position in CBPO in Q1 2016 and held it in 3 quarters. The position peaked at $49K in Q1 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

Northwestern Mutual Wealth Management reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 432 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $47K.
Northwestern Mutual Wealth Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 3 quarters.
Northwestern Mutual Wealth Management's China Biologic Products Holdings, Inc. position peaked at $49K in Q1 2016.
137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.